Latest filing published 11 Jan 2023 for Imago BioSciences, Inc., €875k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Dennis Henner discloses dealings in 4 companies, chiefly Forty Seven, Inc., Humanigen, Inc and Pharmasset Inc. In total, 10 filings cover trades dated from 2 April 2008 to 11 January 2023.
In open-market terms, that means 1 purchase worth €2.7M on one side and 2 sales worth €69k on the other. On balance, insiders were net buyers of €2.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 11 January 2023 with a transaction (€875k) in Imago BioSciences, Inc. The most recent open-market purchase was published on 2 July 2018, 3,036 days ago. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 9 declarations